Lilly Stock Jumps After Phase 3 Weight-Drug Readout
Lilly stock jumps after Phase 3 readout for a next-generation weight-loss drug exceeded expectations. Investors see d...
Explore the primary drivers of risk in Dividend Aristocrats ETF, including sector shifts and interest-rate impacts, with practical mitigation tips.
26,217 articlesLilly stock jumps after Phase 3 readout for a next-generation weight-loss drug exceeded expectations. Investors see d...
Anthropic’s Boris Cherny says he oversees a growing fleet of AI agents, signaling a dramatic shift in software develo...
Tesla's China Sales Just Jumped 22% in May, ending a slump. This article breaks down what's behind the rebound, wheth...
Oil prices hold near the mid-90s as China’s lower imports and strategic reserves cushion short-term shocks. Analysts ...
Tesla commands a market cap near $1.5 trillion, fueling questions about whether tesla worth more than the rest of the...
U.S. stock futures climbed Friday as fresh analyst notes highlighted upside in Adobe, AMD, Coca-Cola, and other names...
Stocks drift lower in mid-June 2026 as investors reassess AI and chip names. This guide lays out what look when buyin...
Investors face a pivotal choice in 2026: chase the next NVIDIA or buy the real thing. The AI stock rotation puts AMD ...
Toast stock could be a rare restaurant technology winner, built on a scalable platform. This analysis lays out why lo...
Adobe and LinkedIn launch a free upskilling program for marketers as AI demand climbs, featuring four concise tracks ...
A single company’s three engines—cloud, ads, and chips—are powering a persistent multi‑billion revenue trajectory, ev...
A federal watchdog report finds a notable denial rate for prior authorizations in Medicare Advantage plans, with wide...